ASN Kidney Week 2022
ASN Kidney Week 2022
Advertisement
Victoria SochaASN Kidney Week 2022 | May 24, 2024
Patients with end-stage renal disease (ESRD) are at increased risk for adverse outcomes from COVID-19 infection. The ...
Read More
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Obesity is associated with risk for complications related to kidney biopsy. Long Qian, MD, and colleagues conducted an ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
The most common monogenic nephropathy is autosomal dominant polycystic kidney disease (ADPKD). ADPKD is associated with ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Decline in renal function is associated with hyperuricemia and gout. Independent of chronic kidney disease (CKD) stage, ...
Victoria SochaASN Kidney Week 2022 | May 24, 2024
Studies have shown that there are racial and ethnic disparities in the type of arteriovenous access ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Masatomo Ogata, MD, and colleagues previously reported results of a study examining the short-term efficacy of ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
With the increase in the prevalence of primary pediatric hypertension comes an emphasis on active research to identify ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Results of the MIRROR randomized controlled trial comparing cotherapy of pegloticase plus methotrexate (MTX) with ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
The most common inherited chronic kidney disease (CKD) is autosomal dominant polycystic kidney disease (ADPKD). Patients ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Patients who develop proteinuria experience increases in urinary copper excretion. Manuela Yepes Calderon, PhD, and ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Among patients with liver failure with renal dysfunction, combined liver-kidney transplantation improves patient ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Patients with acute kidney injury (AKI) are at risk of progression to chronic kidney disease (CKD) and end-stage renal ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Immunomodulator cotherapy has been shown to improve the efficacy of pegloticase by reducing its immunogenicity. Results ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Among patients with end-stage kidney disease (ESKD) receiving maintenance dialysis, sarcopenia is a frequent, yet ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Results of recent studies have suggested an association between low levels of serum magnesium and kidney injury. ...
Advertisement
Advertisement
Advertisement
Latest News

December 3, 2024